Table 2 Top five adverse events (all) associated with TP versus IPC
Adverse effects | No. of studies | TP group (event/total) | IPC group (event/total) | RR (95% CI) | P value | Heterogeneity | |
|---|---|---|---|---|---|---|---|
I2 (%) | P value | ||||||
Dyspnea/breathlessness | 2 | 8/119 | 7/119 | 1.15 [0.43, 3.06] | 0.78 | 0 | 0.42 |
Catheter blockage | 2 | 1/126 | 13/126 | 0.11 [0.02, 0.57] | 0.009 | 0 | 0.82 |
Cellulitis | 2 | 1/126 | 10/126 | 0.14 [0.03, 0.77] | 0.02 | 0 | 0.85 |
Pleural infection | 1 | 1/54 | 7/52 | 0.14 [0.02, 1.08] | 0.06 | NA | NA |
Pain | 1 | 1/48 | 2/46 | 0.48 [0.04, 5.11] | 0.54 | NA | NA |